Research Projects & Grants

• Electrophysiologic Response of the Extensor Digitorum Brevis to Varying Doses of Intramuscularly Injected Botulinum Toxin Type B in Normal Subjects, Role: PI, (07/1994 - 07/1995) Status: Completed
• Evaluation of the Dose Response Effect of Botulinum Toxin on Extensor Digitorum Brevis M-Wave Amplitude: A Pilot Study, Role: PI, (04/1994 - 04/1995) Status: Completed

For Profit Organization

• Titration to response: Analysis of individualized therapy study (TRAITS) Protocol Capss -048, Role: Investigator, Ortho-McNeil Pharmaceutical, (06/1999 - 06/2000) Status: Completed
• A phase III, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the safety and efficacy of a 24-hr infusion of Cervene in patients with acute ischemic stroke, Role: Investigator, Baker Norton Pharmaceuticals, (06/1997 - 06/1998) Status: Completed
• Dose response curve of human extensor digitorum brevis muscle function to intramuscularly injected botolinum a toxin in subjects who have previously received multiple botulinum toxin injections, Role: PI, Allergan Inc., (05/1997 - 05/1998) Status: Completed
• A Trial of Recombinant Methionyl Human Brain-Derived Neurotrophic Factor (r-metHuBDNF)Given by Daily Subcutaneous Injection to Patients with Amyotrophic Lateral Sclerosis (ALS). [Advertising Stage], Role: Investigator, Amgen, Inc., (07/1995 - 07/1996) Status: Completed

Internal

• A study of midodrine in patients with neurogenic orthostatic hypotension. Protocol #20.762-999A, Role: PI, LLU Dept. of Neurology, (07/1996 - 07/1997) Status: Completed